Cargando…
Low molecular weight proteins and enzymes in the urine of patients with bladder cancer – a pilot study
INTRODUCTION: A steady increase in cases of bladder cancer (BC) has been observed. Detection of unfavorable changes, especially in the early stages of disease, is crucial to medical procedure. There is still a need to search for new, non-invasive biomarkers of BC. The aim of this study was to estima...
Autores principales: | Marchewka, Zofia, Szymańska, Beata, Dembowski, Janusz, Długosz, Anna, Piwowar, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Urological Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202615/ https://www.ncbi.nlm.nih.gov/pubmed/30386648 http://dx.doi.org/10.5173/ceju.2018.1661 |
Ejemplares similares
-
Selected biochemical parameters in the urine of HIV-infected patients in monitoring of kidney function
por: Szymańska, Beata, et al.
Publicado: (2021) -
The Dependence between Urinary Levels of Angiogenesis Factors, 8-Iso-prostaglandin F2α, ɣ-Synuclein, and Interleukin-13 in Patients with Bladder Cancer: A Pilot Study
por: Szymańska, Beata, et al.
Publicado: (2020) -
Initial Evaluation of Uroplakins UPIIIa and UPII in Selected Benign Urological Diseases
por: Szymańska, Beata, et al.
Publicado: (2021) -
Preliminary Evaluation of the Diagnostic Usefulness of Uroplakin 2 with an Assessment of the Antioxidant Potential of Patients with Bladder Cancer
por: Matuszewski, M., et al.
Publicado: (2018) -
Uroplakin IIIa Is a Marker in Bladder Cancer but Seems Not to Reflect Chemical Carcinogenesis
por: Szymańska, B., et al.
Publicado: (2018)